ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2474

Patients’ Experiences of Using a Smartphone App for Remote Monitoring of Rheumatoid Arthritis, Integrated into the Electronic Medical Record, and Its Impact on Consultations

Lynn Austin1, Caroline Sanders2 and William G Dixon3, 1Centre for Primary Care, University of Manchester (UK), Manchester M21 9JD, United Kingdom, 2Institute of Population Health, Centre for Primary Care, The University of Manchester, Manchester, United Kingdom, 3Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, Great Britain

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: digital technologies, patient outcomes and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Treatment of patients with rheumatoid arthritis (RA) is guided by monitoring changes in disease severity. At present, patients do not routinely record disease severity between clinic visits, despite the availability of a range of validated patient reported outcome measures (PROMs). In response this, the REMORA study (REmote MOnitoring of Rheumatoid Arthritis) is developing and evaluating a Smarthphone app which patients can use to record key ePROS (electronic patient reported outcomes) between clinic visits, and link these to the electronic patient record (EPR). The aim of this analysis is to examine patients’ views of using the beta version of the app and explore its impact on their post-app clinical consultation. In particular we were interested in seeing if the app could overcome some of the limitations of the current consultation process, i.e. reliance on patient recall, eloquence and stoicism regarding their symptoms between clinic visits.

Methods: The ‘beta app’ was tested by eight patients for one month during which they completed routine question sets at home, with the data integrated into the hospital EPR. Question sets included seven visual analogue scales for daily symptoms including pain and fatigue; weekly self-reported count of tender and swollen joints, flares, and impact on work; and monthly completion of the health assessment questionnaire (HAQ). A free text diary function was provided for ad hoc recording of information, although this wasn’t exported into the record. Patients were invited to a clinical consultation ‘pre’ and ‘post’ app use. These were used to determine the value of having access to routinely recorded ePROS at the consultation. Individual interviews were held with participants to discuss their experience of using the app and the use of the data as part of the clinical consultation. Feedback was also obtained from the consulting clinician.

Results: Patients’ felt that the app was “a great idea” and made care “more personal to you”. Data recording improved the consultation as it aided recall and made it easier for patients to have a “shared conversation” with the clinician at the consultation as “with a graph…you can see what’s going on.” “I found it made a difference, because it wasn’t all me telling him and trying to remember. The information was there so you’ve got solid proof straightaway” These views were echoed by the consulting clinician as the ePROS made it possible to quantify responses to treatment across physical and mental health. The graphs highlighted flares that patients hadn’t mentioned, and demonstrated gradual improvements in symptoms in response to treatment that may otherwise have been missed, therefore supporting decision making regarding the continuation of treatment. Routine completion of data was relatively straightforward – “it’s a doddle” – and not too onerous. A number of minor refinements to the app design and question sets were suggested by patients and will be incorporated into the app.

Conclusion: The app was well received by patients and feedback suggests that the data recorded will have a number of benefits for both patients and clinicians.


Disclosure: L. Austin, None; C. Sanders, None; W. G. Dixon, None.

To cite this abstract in AMA style:

Austin L, Sanders C, Dixon WG. Patients’ Experiences of Using a Smartphone App for Remote Monitoring of Rheumatoid Arthritis, Integrated into the Electronic Medical Record, and Its Impact on Consultations [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/patients-experiences-of-using-a-smartphone-app-for-remote-monitoring-of-rheumatoid-arthritis-integrated-into-the-electronic-medical-record-and-its-impact-on-consultations/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-experiences-of-using-a-smartphone-app-for-remote-monitoring-of-rheumatoid-arthritis-integrated-into-the-electronic-medical-record-and-its-impact-on-consultations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology